Figure 1: Global Recombinant Human EGF Market Share, (%), Analysis, By Application, 2021
Growing research in the field of recombinant technology is the major factor that is expected to drive the market growth over the forecast period.
The rising cases of chronic wounds, corneal damage, acute wounds, and others are expected to drive growth of recombinant human EGF market over the forecast period. For instance, a report published by Ecronicon in May 2020, stated that the prevalence of foot ulcers was 4-10% across the globe and on an average of 17.2 million hospital visits per year were concerned with wound treatments.
Moreover, the increasing number of research and development activities for exploring various uses of recombinant human EGF is expected to aid in the growth of the market over the forecast period. For instance, according to a research study published by NCBI (National Center for Biotechnology Information) in July 2020, Ocean University of China, and Luoyang Normal University, China developed a new delivery system using nanoparticles for the delivery of recombinant human EGF to the wound site. This novel system helps in improving bioavailability of EGF at the wound site and also help in maintaining its sustained release.
Recombinant Human (EGF) Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients